Angiotensin II (Ang II) stimulates cardiac remodelling and fibrosis in the mechanically overloaded myocardium. Although Rho GTPases regulate several cellular processes, including myocardial remodelling, involvement in mediating mechanical stretch-induced regulation of angiotensinogen (Ao), the precursor to Ang II, remains to be determined. We, therefore, examined the role and associated signalling mechanisms of Rho GTPases (Rac1 and RhoA) in regulation of Ao gene expression in a stretch model of neonatal rat cardiac fibroblasts (CFs).
Introduction
Mechanical stress is a major stimulus responsible for the functional and structural changes that occur in the haemodynamically overloaded myocardium. The renin -angiotensin system (RAS) is activated in the pressure-overloaded myocardium and has a major role in mediating both hypertrophy and remodelling of the heart. 1 Several clinical and experimental studies have demonstrated that angiotensinconverting enzyme (ACE) inhibitors and Ang II type I receptor (AT 1 R) antagonists prevent and/or reverse the cardiac hypertrophy and myocardial remodelling caused by hypertension and mechanical load. 2, 3 All components of the RAS (renin, Ao, ACE, Ang II, Ang II receptors) are present in the ventricular myocardium and produced by cardiac fibroblasts (CFs). 1, 4, 5 Targeted overexpression of Ao in the myocardium results in increased cardiac Ang II and ventricular hypertrophy, 6 suggesting that locally produced Ao can induce heart failure.
The mechanisms by which mechanical stress regulates Ao gene expression in CFs remain to be determined. Like their myocyte counterparts, cultured CFs display immediate signalling responses to mechanical stretch. 7, 8 b 1 integrin is a major mechanosensor in cardiac cells and couples to effector systems involved in the regulation of cellular growth and gene expression. 9, 10 Primary effectors activated by b 1 integrin include Rho GTPases 11 and stress-activated protein kinases (SAPKs). 12 SAPKs (such as JNK and p38) have been shown to be downstream targets of Rho GTPases in non-cardiac cells, 13 whereas JNK and p38 are important for stretch-induced regulation of Ao expression in cardiac myocytes and fibroblasts.
14 Rho GTPases, Rac1 and RhoA, have been implicated in pathophysiology of many major cardiovascular diseases, such as hypertension, heart failure, myocardial infarction, and atherosclerosis. 15 Inhibition of Rho-kinase, a potent RhoA effector, blunts the process of left ventricular hypertrophy leading to cardiac contractile dysfunction in hypertension-induced heart failure. 16, 17 However, the role of Rho
GTPases in stretch-induced Ao gene expression is not known. Thus, in the present study, we examined the role of Rac1 and RhoA in mediating b 1 integrin-induced JNK and p38 activation, as well as regulation of Ao gene expression in stretched CFs.
Methods

Preparation of neonatal rat CF cultures
CFs were prepared from hearts of newborn (0 -2 day old) SpragueDawley rat pups, as described. 14 Cells were passaged, attached to deformable membranes coated with collagen-IV and serum-starved for experiments as described in the Supplementary material online, Section 1. For all the stretch experiments, cells were exposed to 20% equiaxial stretch, which mimics in situ pathological conditions. This study conforms to the Guide for the Care 
Adenovirus infection of cells
Twelve hours after plating, CFs were infected for 24 h with an optimal MOI of adenovirus [45 MOI for green fluorescent protein (GFP), dominant-negative Rac1-N17 (Rac1-DN) and dominant-negative RhoA-N19 (Rho-DN); constitutively active Rac1-V17 (Rac1-CA) and constitutively active RhoA-V19 (RhoA-CA); 300 MOI for LacZ and Tac b 1 ] in serum-free DMEM/Medium 199. Determination of expressed proteins in CFs was done using flow cytometry and western blot analysis. Amplification of adenoviruses is described in the Supplementary material online, Section 2.
Preparation of cell lysates and western blot analysis
Cell lysates for western blot analysis were obtained by scrapping CFs into assay lysis buffer (Cell Signaling Technology, Inc., Danvers, MA, USA) supplemented with 10 mg/mL aprotinin, 10 mg/mL leupeptin, 1 mM 4-(2-aminoethyl)-benzenesulfonyl fluoride hydrochloride, and 1 mM sodium orthovanadate (see Supplementary material online, Section 3). Insoluble cell debris was removed by centrifugation (25 000 g) for 10 min at 48C and cell lysates were boiled with Laemmli sample buffer [0.5 mol/L Tris -HCl (pH 6.8), 10% SDS, 10% glycerol, 4% b-merceptoethanol, and 0.05% Bromphenol Blue]. Western blot analysis was performed as described in the Supplementary material online, Section 3.
Rac1 and RhoA activity assays
Procedures for performing Rac1 and RhoA activity assays are detailed in the Supplementary material online, Section 4. CFs were stretched for various times after adenovirus-assisted transfection. Immediately after stretch, CFs were lysed in the commercially available (Boston BioProducts, Worcester, MA, USA) RIPA lysis buffer supplemented with protease inhibitor cocktail, followed by centrifugation (25 000 g) for 10 min at 48C. Equal volumes of cell lysate were incubated with GST -PBD and GST -RBD beads (prepared as described in the Supplementary material online, Section 5) and incubated for 60 min at 48C as previously described. 18 grown to 60% confluence (2 days) in DMEM containing 10% newborn calf serum. The medium was changed to serum-free MEM and immunostaining was performed 24 h later. Prior to immunostaining, CFs were washed with PBS and fixed with Streck Tissue Fixative (Omaha, NE, USA) and permeabilized for 5 min using 0.05% Tritonw 100. CFs were incubated for 1 h (228C) with 5% bovine serum albumin to block non-specific binding. Cells were then incubated at 378C for 1.5 h with primary antibodies for Rac-1, RhoA, or b 1 integrin (Ha2/5, BD Transduction laboratory) and 45 min with the appropriate secondary antibody conjugated to Alexa-488 or Alexa 594 (Invitrogen). Samples were covered with mounting media [Prolong w Gold antifade reagent containing 4 ′ ,6-diamidino-2-phenylindole (DAPI), Invitrogen], overlaid with coverslips and examined on an Olympus Fluoview 1000 microscope.
Statistics analysis
Results are expressed as the means + standard error of the means (SEM), computed from separate experiments. Comparisons between control and experimental groups were performed using the Student's group t-test. Multiple comparisons among treatment groups were performed using one-way analysis of variance (ANOVA) and by two-way ANOVA and levels of significance determined using the Tukey-Kramer multiple comparison post-hoc test (GraphPad prism Software, Inc., San Diego, CA, USA). P-values ,0.05 were considered to be statistically significant.
Results
Time course of stretch-induced activation of Rac1 and RhoA in CFs
In order to characterize the temporal effects of mechanical stretch on Rac1 and RhoA activation in CFs, we measured Rac1 and RhoA activity from 2 min to 24 h. Rac1 was significantly activated within 2 min after stretch (fold change compared with no stretch; 2 min 1.73 + 0.190, P , 0.01; 5 min 2.89 + 0.365, P , 0.01; 10 min 2.92 + 0.408, P , 0.01; 15 min 2.50 + 0.359, P , 0.01) and declined after 15 min, which continued until 24 h ( Figure 1A and B) . Interestingly, RhoA was activated within 2 min after stretch (fold change compared with no stretch; 2 min 1.70 + 0.092, P , 0.05; 5 min 2.30 + 0.319, P , 0.01; 10 min 2.40 + 0.358, P , 0.01; 15 min 3.10 + 0.449, P , 0.01). In contrast to Rac1, RhoA demonstrated marked activation at later time points (fold change compared with no stretch; 16 h 2.84 + 0.36, P , 0.01; 24 h 3.16 + 0.495, P , 0.01) ( Figure 1A and C).
Time course of stretch-induced activation of SAPKs, p38, and JNK in CFs.
To determine the temporal effects of stretch on SAPKs activation, CFs were stretched from 2 min to 24 h. Results from western blot analysis performed on cell lysates indicate that initially from 5 to 15 min, both p38 and JNK were activated by stretch (Supplementary material online, Figure S1A -C). JNK activity was significantly increased and peaked at 10 min (fold change compared with no stretch; 3.46 + 0.319, P , 0.01), and gradually diminished to control levels for the remaining portion of the stretch period. p38 activation was biphasic, with initial activation at 2-15 min, followed by a decline and subsequent rise after 2 h, and remained activated until the end of the 24 h study period (fold change compared with no stretch; 1.94 + 0.085, P , 0.01).
Rac1 and RhoA differentially regulate Ao gene expression
Rho GTPases mediate hypertrophic signals in cardiac myocytes. 19, 20 However, no studies have determined whether Rho GTPases couple to Ao gene expression in CFs. To test whether Rac1 and/or RhoA activation may be required for stretch-induced regulation of Ao expression, CFs were infected for 24 h with matched titres of recombinant adenoviruses that express either Rac1-DN, RhoA-DN, or GFP (virus control) ( when Ao gene expression was modestly inhibited, blockade of RhoA function using RhoA-DN resulted in marked expression of Ao in stretched CFs (fold change compared with GFP; 3.39 + 0.094, P , 0.001). In contrast, expression of Rac1-DN adenovirus had no effect on stretch-induced inhibition of Ao gene expression ( Figure 2G ). On the other hand, chronic stretch (24 h) significantly upregulated Ao gene expression (fold change compared with NS; 3.39 + 0.044, P , 0.001) and Rac1-DN expression had no significant effect on stretch-mediated Ao gene expression ( Figure 2H) . Interestingly, RhoA-DN expression considerably reduced this stretch response. These data indicate that RhoA has an important role in regulating stretch-induced Ao gene expression at both early and later stages of mechanical stretch, whereas Rac1 appears to have only a minimal role in this process ( Figure 2H ). This is supported by time course results, in which stretch-induced Ao expression corresponded to latter time points (24 h) in which RhoA was markedly increased. 3.5 b 1 integrin couples to stretch-induced activation of SAPKs, p38, and JNK Previous studies suggest that JNK and p38 are activated in the left ventricle during pressure overload-induced cardiac remodelling. 22 In cardiac myocytes, the rapid activation of MAP kinases in response to mechanical stimulation has been well documented. 23, 24 Though less investigated, activation of MAP kinases has also been observed in CFs subjected to short durations of mechanical stretch. 8 In the Figure 4A and B).
Rac1 and RhoA couple to Ao expression through SAPKs
The above results demonstrate that b 1 integrin plays a predominant role in at least the initial activation of Rac1, RhoA, and SAPKs. To determine whether Rac1 and RhoA couple to SAPKs cascades, CFs infected with Rac1-DN and RhoA-DN were stretched for 2 and 15 min, and SAPKs activities were measured by western blot analysis.
Results revealed that Rac1 blockade increased p38 phosphorylation gene expression in cells expressing Rac1-CA ( Figure 6A) . These results suggest that Rac1 can also inhibit Ao gene expression via a JNK-independent pathway. Treatment of CFs with p38 pharmacological inhibitor, completely abolished the stimulatory effects on Rho-CA on Ao gene expression ( Figure 6B ), suggesting that p38 is the primary downstream effector. These results suggest that Rac1 is an upstream activator of JNK, whereas RhoA is an upstream activator of p38.
Discussion
Rho GTPases participate in cardiac remodelling and fibrosis in the mechanically overloaded myocardium. In the present study, we explored the regulatory effects of Rac1 and RhoA on Ao gene expression in mechanically stretched CFs. Results of this work demonstrated that stretch-induced regulation of Ao gene expression in CFs is primarily mediated by RhoA. Our results also indicate that with chronic stretch, p38 (stress-activated protein kinase) is a downstream target for RhoA and during this time, RhoA activation is independent of b 1 integrin. The role of integrins in the activation and translocation of SAPK to the nucleus is well established in other cells. 25 Moreover, we have reported the involvement of SAPKs (p38 and JNK) in regulation of Ao gene expression in both cardiac myocytes and fibroblasts. 14 However, the role of upstream activators of SAPK as well as downstream effectors of b 1 integrin is not clearly known in CFs. A recent study has demonstrated that inhibition of Rho signalling by Clostridium difficle toxin B (Rac1 and RhoA inhibitor) or C3 exoenzyme (RhoA inhibitor) inhibited stretch-induced activation of both p38 and JNK in cardiac myocytes. 26 In the present study, we demonstrated p38 and JNK in CFs to be regulated by RhoA and Rac1, respectively. As expected, stretch-induced early activation of JNK was significantly inhibited by expression of Rac1-DN, indicating that Rac1 is an upstream activator of JNK-signalling. This is consistent with previous work showing that endothelin-1 (hypertrophic stimulus)-induced activation of JNK was attenuated by toxin B. 27 Interestingly, stretch-induced p38 activity was enhanced in CFs expressing dominant-negative Rac1, indicating that the Rac1/JNK pathway is a negative regulator of p38. In contrast to Rac1, previous studies suggest that RhoA is a mediator of hypertrophic responses in the myocardium. 28, 29 In a recent study, inhibition of the RhoA effector ROCK, using the ROCK inhibitor GSK 576371, was found to prevent left ventricular hypertrophy and reduce collagen deposition, which were accompanied by improved diastolic function in pressure overload-induced cardiac hypertrophy in the rat. 17 In the diabetic mouse heart, which has reduced ventricular performance, RhoA has been shown to activate p38, which is also activated in the failing myocardium. 30, 31 It has been demonstrated that p38 inhibition improves cardiac function and attenuates cardiac remodelling following myocardial infarction. 32 Recent studies also suggest that p38
and JNK may engage in negative cross-talk during heart failure. 22 Our results also suggest that regulatory interactions between p38 and JNK are time-dependent. Stretch initially activated both p38 and JNK (2-15 min), however, with prolonged stretch there was a loss in JNK activity (30 min-24 h). In contrast, p38 remained active until 24 h. It is possible that prolonged activation of p38 results in inactivation of JNK via early immediate gene expression 33 and/or release of autocrine factors. 34 Stretch-induced differential regulation of Rho GTPases and hence JNK and p38, may be due to differential regulation of RhoA and Rac1 by one or more upstream regulators. Earlier studies have demonstrated that chronic stretch induces b 1 integrin expression in cardiac myocytes. 35 The present study indicates that 2-15 min following mechanical stretch, b 1 integrin was an important regulator of Rac1 and RhoA activity, whereas b 1 integrin-independent signalling mechanisms were important afterwards. Mechanosensing and autocrine regulators of Rac1 and RhoA following prolonged (.30 min) stretch remain to be explored in CFs and other cell systems.
In contrast to our previous study performed in pure cultures of cardiac myocytes, 12 blockade of b 1 integrin inhibited JNK activation and stimulated p38. The possible cell type differences in these responses may be due to differences in coupling of b 1 integrin to Rho GTPases and/or coupling between Rho GTPases to SAPK. It has been reported that 4% stretch caused rapid activation of JNK, and this activation is mediated by integrin receptors in CFs. 8 Moreover, extracellular matrix components exert a significant role on the stretch-induced activation of JNK in this model, although p38 activity was unaffected. In contrast to the above studies, expression of Tac b 1 inhibited the stretch-induced JNK activation in our model, however, p38 activity was further improved under this treatment.
The differential response of b 1 integrin in our stretch model may be due to differences in the extracellular matrix and intensity of stretch (20% as in our model). This result further confirms our hypothesis that b 1 integrin, either by activating Rac1 or inhibiting RhoA, can modulate both JNK and p38 activities. The activities of JNK and p38 are important in the regulation of Ao in the myocardium. Because Rac1 and RhoA differentially regulate JNK with regard to p38, we sought to understand the roles of Rac1 and RhoA on stretch-induced activation of Ao by expressing Rac1-DN and RhoA-DN in CFs. Intriguingly, a remarkable inhibition of stretch-induced activation of Ao gene expression was observed in RhoA-DN-treated CFs. However, CFs infected with Rac1-DN further sustained the stretch-induced Ao gene expression. This result also suggests that the initial inhibition of Ao by stretch (2-4 h) may be due to activation of Rac1, while Rac1 is concomitantly activating JNK. Although JNK appears to be an important downstream target of Rac1 and important negative regulator of Ao expression, the inability of JNK1/2 inhibitor to block downregulation of Ao expression in CFs expressing constitutively active Rac1 suggests that a JNK-independent inhibitory pathway is also operational. This is consistent with a recent study in which Rac1 was shown to directly phosphorylate the transcriptional repressor B-cell lymphoma 6 (BCL-6) proto-oncogene, independent of Rac1-induced Jun N-terminal kinase activation. 36 Interestingly, one of the downstream targets of BCL-6 is p50 nuclear factor-kappaB1, 36 which stimulates Ao gene transcription in the liver. 37 In contrast to Rac1, the stimulatory effects of RhoA on Ao gene expression in CFs appeared to be solely dependent on p38 activation. Pursuant to our current knowledge, this is the first study to suggest that Rac1 and RhoA regulate Ao gene expression in CFs. The role of integrins on myocardial functions and progression of heart disease is still an issue of debate. Recently, several investigators have suggested that b 1 integrin can promote mechanical stretchinduced cardiac hypertrophy and remodelling, 38, 39 however, other in vivo and in vitro studies suggest that b 1 integrin inhibits these responses. 40, 41 In a recent study, moderate spontaneous cardiac hypertrophy associated with systolic and diastolic dysfunction was reported in b 3 integrin knockout mice, and these defects were worsened by thoracic aortic constriction. 42 Defects in b 1 integrin resulting in myocardial dysfunction after myocardial infarct also suggest that it is protective. In the present study, the inhibitory effects of b 1 integrin on the RhoA-p38 signalling cascade and stimulatory effects of b 1 integrin on Rac1-JNK signalling also suggest a protective role of b 1 integrin during chronic and acute stretch conditions, respectively in CFs.
Although results from the present study provide evidence for the role of Rho GTPases in mechanical stretch-induced Ao gene expression, it will be important to identify the downstream effector systems responsible for mediating the regulatory effects of Rac1 and RhoA on Ao transcription and/or mRNA stability in CFs.
In conclusion, considerable progress has been made regarding the role of Rac1 and RhoA in cardiac myocyte signalling and hypertrophy in the past decade. The implication of these findings is that activation of RhoA/p38 signalling pathways mediate stretch-induced activation of Ao gene expression in CFs and could, therefore, contribute to the hypertrophic response observed in the haemodynamically overloaded myocardium. Thus, our findings provide new insights into how mechanotransduction may alter Ao levels, which can maintain normal cardiac physiology or initiate pathological responses.
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